Demonstration of mutations conferring resistance to lamivudine in liver tissue of chronic hepatitis B patients under lamivudine therapy

İsmail Yaşar AVCI; Can Polat EYİGÜN; Emine GÜNAL; Ayhan KUBAR; Hanefi Cem GÜL; Ömer COŞKUN; Hakan ERDEM; Levent GÖRENEK; Bülent Ahmet BEŞİRBELLİOĞLU

Makale detayları

Demonstration of mutations conferring resistance to lamivudine in liver tissue of chronic hepatitis B patients under lamivudine therapy

Yazarlar:

İsmail Yaşar AVCI | Can Polat EYİGÜN | Emine GÜNAL | Ayhan KUBAR | Hanefi Cem GÜL | Ömer COŞKUN | Hakan ERDEM | Levent GÖRENEK | Bülent Ahmet BEŞİRBELLİOĞLU

Yayıncı:

TUBITAK

Dergi:

Turkish Journal of Medical Sciences 2013 Vol.43 Issue 2, pp.199-202

Belge Tipi:

Makale

Yayın Tarihi:

1/2013

Belge Dili:

Türkçe

Document ID (Org No.):

2000753773

Sıklık:

İki Aylık

eISSN:

1303-6165

pISSN:

1300-0144

Anahtar kelimeler:

Özet:

 

To demonstrate the genotypic lamivudine resistance in liver tissue of patients with negative serum hepatitis B virus (HBV) DNA under long-term lamivudine therapy.  Materials and methods: Fourteen patients (10 patients with elevated alanine aminotransferase and 4 patients under long-term lamivudine therapy for severe liver disease) with undetected serum HBV DNA were included in the study. A liver biopsy was performed for each patient, and HBV DNA extracted from liver tissue was analyzed with TaqMan real-time polymerase chain reaction.  Results: Mutations conferring lamivudine resistance were shown for all 14 patients in their liver tissue-extracted HBV DNA. One patient had rtM204V, 4 patients had rtL180M, 2 had rtL180M + rtM204V, 4 had rtL180M + rtM204I, and 3 had rtL180M + rtM204I + rtM204V substitutions.  Conclusion: Analyzing mutation in liver tissues of these patients might help demonstrate resistance earlier and prevent delaying of therapeutic modification. Therefore, all liver biopsy specimens of patients with severe liver fibrosis should be analyzed using the molecular technique.

 

To demonstrate the genotypic lamivudine resistance in liver tissue of patients with negative serum hepatitis B virus (HBV) DNA under long-term lamivudine therapy.  Materials and methods: Fourteen patients (10 patients with elevated alanine aminotransferase and 4 patients under long-term lamivudine therapy for severe liver disease) with undetected serum HBV DNA were included in the study. A liver biopsy was performed for each patient, and HBV DNA extracted from liver tissue was analyzed with TaqMan real-time polymerase chain reaction.  Results: Mutations conferring lamivudine resistance were shown for all 14 patients in their liver tissue-extracted HBV DNA. One patient had rtM204V, 4 patients had rtL180M, 2 had rtL180M + rtM204V, 4 had rtL180M + rtM204I, and 3 had rtL180M + rtM204I + rtM204V substitutions.  Conclusion: Analyzing mutation in liver tissues of these patients might help demonstrate resistance earlier and prevent delaying of therapeutic modification. Therefore, all liver biopsy specimens of patients with severe liver fibrosis should be analyzed using the molecular technique.

Makale detayları

Demonstration of mutations conferring resistance to lamivudine in liver tissue of chronic hepatitis B patients under lamivudine therapy

Yazarlar:

İsmail Yaşar AVCI | Can Polat EYİGÜN | Emine GÜNAL | Ayhan KUBAR | Hanefi Cem GÜL | Ömer COŞKUN | Hakan ERDEM | Levent GÖRENEK | Bülent Ahmet BEŞİRBELLİOĞLU

Yayıncı:

TUBITAK

Dergi:

Turkish Journal of Medical Sciences 2013 Vol.43 Issue 2, pp.199-202

Belge Tipi:

Makale

Yayın Tarihi:

1/2013

Belge Dili:

Türkçe

Document ID (Org No.):

2000753773

Sıklık:

İki Aylık

eISSN:

1303-6165

pISSN:

1300-0144

Key words: Mutation

liver tissue

HBV DNA

Sayı

Makale detayları

Demonstration of mutations conferring resistance to lamivudine in liver tissue of chronic hepatitis B patients under lamivudine therapy

Yazarlar: İsmail Yaşar AVCI | Can Polat EYİGÜN | Emine GÜNAL | Ayhan KUBAR | Hanefi Cem GÜL | Ömer COŞKUN | Hakan ERDEM | Levent GÖRENEK | Bülent Ahmet BEŞİRBELLİOĞLU

Yayıncı: TUBITAK

Dergi: Turkish Journal of Medical Sciences 2013 Vol.43 Issue 2, pp.199-202

Belge Tipi: Makale

Yayın Tarihi: 1/2013

Belge Dili: Türkçe

Document ID (Org No.): 2000753773

Sıklık: İki Aylık

eISSN: 1303-6165

pISSN: 1300-0144

Key words: Mutation

liver tissue

HBV DNA

Sayı

Yazarlar:

İsmail Yaşar AVCI | Can Polat EYİGÜN | Emine GÜNAL | Ayhan KUBAR | Hanefi Cem GÜL | Ömer COŞKUN | Hakan ERDEM | Levent GÖRENEK | Bülent Ahmet BEŞİRBELLİOĞLU

Yayıncı:

TUBITAK

Dergi:

Turkish Journal of Medical Sciences 2013 Vol.43 Issue 2, pp.199-202

Belge Tipi:

Makale

Yayın Tarihi:

1/2013

Belge Dili:

Türkçe

Document ID (Org No.):

2000753773

Sıklık:

İki Aylık

eISSN:

1303-6165

pISSN:

1300-0144